Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026)
Artivion's (AORT) quarterly Liabilities and Shareholders Equity came in at $883.2 million in Q1 2026, up 11.63% YoY from $791.2 million in Q1 2025, and little changed on a QoQ basis from $884.8 million in Q4 2025.
Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Artivion (AORT) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $883.2 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 11.63% year-over-year to $883.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 billion (up 9.17% YoY) and the FY2025 annual result came in at $884.8 million, up 12.13% from the prior year.
- Liabilities and Shareholders Equity held at $883.2 million in Q1 2026, from $884.8 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $884.8 million in Q4 2025 to a low of $742.7 million in Q3 2022.
- A 5-year average of $798.5 million and a median of $789.1 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 9.27% — and 2025, when it climbed 12.13%.
- Tracing AORT's Liabilities and Shareholders Equity over 5 years: stood at $762.8 million in 2022, then rose by 3.88% to $792.4 million in 2023, then slipped by 0.42% to $789.1 million in 2024, then rose by 12.13% to $884.8 million in 2025, then retreated by 0.19% to $883.2 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $883.2 million (Q1 2026), $884.8 million (Q4 2025), and $857.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Artivion | 1.36 Bn | 1.29 Bn | 80.52 Mn | 1.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Bn |
| Mar 31, 2026 | 883.16 Mn |
| Dec 31, 2025 | 884.80 Mn |
| Sep 30, 2025 | 857.66 Mn |
| Jun 30, 2025 | 838.39 Mn |
| Mar 31, 2025 | 791.16 Mn |
| Dec 31, 2024 | 789.10 Mn |
| Sep 30, 2024 | 803.14 Mn |
| Jun 30, 2024 | 789.54 Mn |
| Mar 31, 2024 | 784.01 Mn |
| Dec 31, 2023 | 792.40 Mn |
| Sep 30, 2023 | 774.79 Mn |
| Jun 30, 2023 | 777.86 Mn |
| Mar 31, 2023 | 757.07 Mn |
| Dec 31, 2022 | 762.80 Mn |
| Sep 30, 2022 | 742.73 Mn |
| Jun 30, 2022 | 764.86 Mn |
| Mar 31, 2022 | 781.86 Mn |
| Dec 31, 2021 | 793.05 Mn |
| Sep 30, 2021 | 818.65 Mn |